Cargando…
Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
Vitamin D deficiency is associated with a higher risk of SARS-CoV-2 infection and poor outcomes of the COVID-19 disease. However, a satisfactory mechanism explaining the vitamin D protective effects is missing. Based on the anti-inflammatory and anti-oxidative properties of classical and novel (CYP1...
Autores principales: | Qayyum, Shariq, Slominski, Radomir M., Raman, Chander, Slominski, Andrzej T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698837/ https://www.ncbi.nlm.nih.gov/pubmed/36432468 http://dx.doi.org/10.3390/nu14224779 |
Ejemplares similares
-
Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs)
por: Slominski, Andrzej T., et al.
Publicado: (2021) -
Vitamin D and Its Derivatives as Promising Drugs Against COVID-19 - A Computational Study
por: Song, Yuwei, et al.
Publicado: (2021) -
OR11-06 Biological Activity Of Lumisterol Hydroxymetabolites And Their Mechanism Of Action
por: Slominski, Andrzej T, et al.
Publicado: (2023) -
CYP11A1-derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas
por: Slominski, Andrzej T., et al.
Publicado: (2022) -
Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?
por: Slominski, Andrzej T., et al.
Publicado: (2020)